• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于变异通路的肺腺癌分期的支持向量机

Support Vector Machine for Lung Adenocarcinoma Staging Through Variant Pathways.

机构信息

Department of Respiratory Medicine, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing China.

Department of Respiratory Medicine, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing China

出版信息

G3 (Bethesda). 2020 Jul 7;10(7):2423-2434. doi: 10.1534/g3.120.401207.

DOI:10.1534/g3.120.401207
PMID:32444360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7341118/
Abstract

Lung adenocarcinoma (LUAD) is one of the most common malignant tumors. How to effectively diagnose LUAD at an early stage and make an accurate judgement of the occurrence and progression of LUAD are still the focus of current research. Support vector machine (SVM) is one of the most effective methods for diagnosing LUAD of different stages. The study aimed to explore the dynamic change of differentially expressed genes (DEGs) in different stages of LUAD, and to assess the risk of LUAD through DEGs enriched pathways and establish a diagnostic model based on SVM method. Based on TMN stages and gene expression profiles of 517 samples in TCGA-LUAD database, coefficient of variation () combined with one-way analysis of variance () were used to screen out feature genes in different TMN stages after data standardization. Unsupervised clustering analysis was conducted on samples and feature genes. The feature genes were analyzed by Pearson correlation coefficient to construct a co-expression network. Fisher exact test was conducted to verify the most enriched pathways, and the variation of each pathway in different stages was analyzed. SVM networks were trained and ROC curves were drawn based on the predicted results so as to evaluate the predictive effectiveness of the SVM model. Unsupervised hierarchical clustering analysis results showed that almost all the samples in stage III/IV were clustered together, while samples in stage I/II were clustered together. The correlation of feature genes in different stages was different. In addition, with the increase of malignant degree of lung cancer, the average shortest path of the network gradually increased, while the closeness centrality gradually decreased. Finally, four feature pathways that could distinguish different stages of LUAD were obtained and the ability was tested by the SVM model with an accuracy of 91%. Functional level differences were quantified based on the expression of feature genes in lung cancer patients of different stages, so as to help the diagnosis and prediction of lung cancer. The accuracy of our model in differentiating between stage I/II and stage III/IV could reach 91%.

摘要

肺腺癌 (LUAD) 是最常见的恶性肿瘤之一。如何在早期有效诊断 LUAD,并对 LUAD 的发生和进展做出准确判断,仍是当前研究的重点。支持向量机 (SVM) 是诊断不同阶段 LUAD 的最有效方法之一。本研究旨在探讨 LUAD 不同阶段差异表达基因 (DEGs) 的动态变化,并通过 DEGs 富集途径评估 LUAD 的风险,建立基于 SVM 方法的诊断模型。基于 TCGA-LUAD 数据库中 517 个样本的 TMN 分期和基因表达谱,通过数据标准化后,采用变异系数 () 结合单向方差分析 () 筛选出不同 TMN 分期的特征基因。对样本和特征基因进行无监督聚类分析。采用 Pearson 相关系数对特征基因进行分析,构建共表达网络。采用 Fisher 精确检验对最富集的通路进行验证,并分析各通路在不同分期的变化。基于预测结果训练 SVM 网络并绘制 ROC 曲线,以评估 SVM 模型的预测效果。无监督层次聚类分析结果表明,III/IV 期几乎所有样本均聚类在一起,而 I/II 期样本聚类在一起。不同分期特征基因的相关性不同。此外,随着肺癌恶性程度的增加,网络的平均最短路径逐渐增加,而接近中心度逐渐降低。最终获得 4 个能够区分 LUAD 不同分期的特征通路,并通过 SVM 模型进行测试,准确率为 91%。基于不同分期肺癌患者特征基因的表达,对功能水平差异进行量化,有助于肺癌的诊断和预测。我们的模型在区分 I/II 期和 III/IV 期的准确率可达 91%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/46d35236da79/2423f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/1b6725ba1a5f/2423f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/24d878cf784a/2423f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/8b6f4743cd7f/2423f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/ca2cc840ced8/2423f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/77b80e98cba3/2423f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/268ccc5d53c1/2423f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/9c687fd9ddfb/2423f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/d306a4fcfb6c/2423f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/d65d198dcfbf/2423f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/46d35236da79/2423f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/1b6725ba1a5f/2423f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/24d878cf784a/2423f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/8b6f4743cd7f/2423f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/ca2cc840ced8/2423f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/77b80e98cba3/2423f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/268ccc5d53c1/2423f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/9c687fd9ddfb/2423f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/d306a4fcfb6c/2423f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/d65d198dcfbf/2423f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa65/7341118/46d35236da79/2423f10.jpg

相似文献

1
Support Vector Machine for Lung Adenocarcinoma Staging Through Variant Pathways.基于变异通路的肺腺癌分期的支持向量机
G3 (Bethesda). 2020 Jul 7;10(7):2423-2434. doi: 10.1534/g3.120.401207.
2
Construction of a 26‑feature gene support vector machine classifier for smoking and non‑smoking lung adenocarcinoma sample classification.构建一个 26 特征基因支持向量机分类器,用于吸烟和非吸烟肺腺癌样本分类。
Mol Med Rep. 2018 Feb;17(2):3005-3013. doi: 10.3892/mmr.2017.8220. Epub 2017 Dec 7.
3
Identification of feature risk pathways of smoking-induced lung cancer based on SVM.基于支持向量机的吸烟诱导肺癌特征风险通路的鉴定。
PLoS One. 2020 Jun 4;15(6):e0233445. doi: 10.1371/journal.pone.0233445. eCollection 2020.
4
Possible pathways used to predict different stages of lung adenocarcinoma.用于预测肺腺癌不同阶段的可能途径。
Medicine (Baltimore). 2017 Apr;96(17):e6736. doi: 10.1097/MD.0000000000006736.
5
Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.基于机器学习和加权基因共表达网络分析筛选人类肺腺癌关键长非编码 RNA。
Cancer Biomark. 2019;25(4):313-324. doi: 10.3233/CBM-190225.
6
A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma.基于十个基因的签名风险评估模型预测肺腺癌的预后。
BMC Cancer. 2020 Aug 20;20(1):782. doi: 10.1186/s12885-020-07235-z.
7
RACGAP1 is a pivotal gene in lung adenocarcinoma-associated membranous nephropathy: Based on comprehensive bioinformatics analysis and machine learning.RACGAP1 是肺腺癌相关膜性肾病的关键基因:基于综合生物信息学分析和机器学习。
Int Immunopharmacol. 2024 Sep 30;139:112783. doi: 10.1016/j.intimp.2024.112783. Epub 2024 Jul 27.
8
Identification of Crosstalk Genes between Lung Adenocarcinoma and Periodontitis.肺腺癌与牙周炎的串扰基因鉴定。
Curr Med Chem. 2024;31(39):6542-6553. doi: 10.2174/0109298673273414231101082153.
9
A feature selection-based framework to identify biomarkers for cancer diagnosis: A focus on lung adenocarcinoma.基于特征选择的癌症诊断生物标志物识别框架:以肺腺癌为例。
PLoS One. 2022 Sep 6;17(9):e0269126. doi: 10.1371/journal.pone.0269126. eCollection 2022.
10
A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data.基于 TCGA 和 GEO 数据的肺腺癌病理分级新型 microRNA 特征。
Int J Mol Med. 2020 May;45(5):1397-1408. doi: 10.3892/ijmm.2020.4526. Epub 2020 Mar 4.

引用本文的文献

1
Inferring evolutionary trajectories from cross-sectional transcriptomic data to mirror lung adenocarcinoma progression.从横断面转录组数据推断进化轨迹,以反映肺腺癌的进展。
PLoS Comput Biol. 2023 May 25;19(5):e1011122. doi: 10.1371/journal.pcbi.1011122. eCollection 2023 May.
2
Construction, validation and, visualization of a web-based nomogram for predicting the overall survival and cancer-specific survival of leiomyosarcoma patients with lung metastasis.构建、验证并可视化用于预测肺转移平滑肌肉瘤患者总生存期和癌症特异性生存期的基于网络的列线图。
J Thorac Dis. 2021 May;13(5):3076-3092. doi: 10.21037/jtd-21-598.

本文引用的文献

1
FeatureSelect: a software for feature selection based on machine learning approaches.FeatureSelect:一款基于机器学习方法的特征选择软件。
BMC Bioinformatics. 2019 Apr 3;20(1):170. doi: 10.1186/s12859-019-2754-0.
2
Semaphorin Signaling in Cancer-Associated Inflammation.信号素在癌症相关炎症中的作用。
Int J Mol Sci. 2019 Jan 17;20(2):377. doi: 10.3390/ijms20020377.
3
Patient and carer perceived barriers to early presentation and diagnosis of lung cancer: a systematic review.患者和照护者对肺癌早期就诊和诊断的认知障碍:系统评价。
BMC Cancer. 2019 Jan 8;19(1):25. doi: 10.1186/s12885-018-5169-9.
4
Feature selection and tumor classification for microarray data using relaxed Lasso and generalized multi-class support vector machine.使用松弛 Lasso 和广义多类支持向量机进行微阵列数据分析的特征选择和肿瘤分类。
J Theor Biol. 2019 Feb 21;463:77-91. doi: 10.1016/j.jtbi.2018.12.010. Epub 2018 Dec 8.
5
Current trends and emerging diagnostic techniques for lung cancer.肺癌的当前趋势和新兴诊断技术。
Biomed Pharmacother. 2018 Oct;106:1586-1599. doi: 10.1016/j.biopha.2018.07.145. Epub 2018 Jul 28.
6
The many faces of lung adenocarcinoma: A pictorial essay.肺腺癌的多样面貌:一篇图文并茂的文章。
J Med Imaging Radiat Oncol. 2018 Oct;62(5):654-661. doi: 10.1111/1754-9485.12779. Epub 2018 Aug 6.
7
Cell death-based treatment of lung adenocarcinoma.基于细胞死亡的肺腺癌治疗方法。
Cell Death Dis. 2018 Jan 25;9(2):117. doi: 10.1038/s41419-017-0063-y.
8
Lung Cancer: Clinical Presentation and Diagnosis.肺癌:临床表现与诊断
FP Essent. 2018 Jan;464:23-26.
9
Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages.上皮-间质转化的比较基因共表达网络分析揭示肺癌进展阶段。
BMC Cancer. 2017 Dec 6;17(1):830. doi: 10.1186/s12885-017-3832-1.
10
Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review.肺癌诊断和治疗的及时性:范围文献综述。
Lung Cancer. 2017 Oct;112:156-164. doi: 10.1016/j.lungcan.2017.08.011. Epub 2017 Aug 15.